Table 2 Correlation of CAR immunopositivity and clinicopathological parameters with patients survival

From: Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression

Clinicopathological parameters

Hazard ratio

95% CI of ratio

P -value

CAR

1.842

1.090–3.727

0.0254

 Positive

   

 Negative

   

Cancer type

1.426

0.6110–3.811

0.3655

 Intestinal

   

 Diffus

   

Tumour differentiation

1.25

0.6883–2.279

0.5432

 G1/G2

   

 G3/G4

   

Tumour infiltration

1.336

0.5772–3.071

0.502

 T1/T2

   

 T3/T4

   

Lymph node metastasis

3.587

1.453–4.808

0.0015

 N0

   

 N1-3

   

Distant metastasis

7.129

29.04–1201

<0.0001

 Absent

   

 Present

   
  1. NOTE: statistically significant correlations are shown in bold face. Survival was determined from the date of surgery to the time of event (death) using the Kaplan–Meier method. Non-cancer-related deaths were excluded from analyses. Statistical significance of differences in cumulative survival curves was evaluated using log-rank tests.